Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Rev. cuba. estomatol ; 47(2): 260-265, abr.-jun. 2010.
Artigo em Espanhol | LILACS, CUMED | ID: lil-584503

RESUMO

El nevus blanco esponjoso (NBE) es una rara condición autosómica dominante, caracterizada por placas blancas bilaterales en la mucosa, de aspecto esponjoso, blandas a la palpación y que pueden escamarse. Los tratamientos son paliativos; y el uso de antibióticos, en especial la tetraciclina, ha demostrando buenos resultados en su control. Este trabajo presenta tres casos clínicos de una familia afectada por NBE, donde se discuten los posibles diagnósticos diferenciales y conductas terapéuticas indicadas. Un paciente masculino de 52 años de edad acudió a la clínica aquejado de lesiones blancas bilaterales. El paciente notó las lesiones 30 años antes, sin lograr un diagnóstico final de las mismas. Después de la anamnesis y del examen clínico fue realizada una biopsia incisional. La reunión de los datos clínicos e histopatológicos llevó al diagnóstico de NBE. Se le solicitó al paciente que indagase entre sus familiares con respecto a lesiones semejantes. Se detectó que el hijo de 19 años y la hija de 25 eran portadores de placas blancas en la mucosa yugal. Como no había afectación estética, se optó por no intervenir en las lesiones. El nevus blanco esponjoso es una lesión genética que debe ser diferenciada de otras patologías localizadas y sistémicas importantes, que tienen repercusiones serias para el individuo. Como no hay un tratamiento curativo para el NBE, el papel del cirujano dentista es diagnosticar esta lesión, aclarar al paciente sobre la naturaleza benigna y autolimitante del NBE y si fuera necesario desde el punto de vista estético, aplicar diferentes modalidades terapéuticas(AU)


The aim of present paper is to introduce three clinical cases from a family affected from nevus spongiosus albus (NSA) and also to discuss the possible differential diagnoses as well as the therapeutical behaviors to be adopted. Clinical case: A man aged 52 seen in our clinic due to bilateral white lesions noted 30 years ago without achieve a final diagnosis of lesions. After anamnesis and physical examination an incision biopsy was taken. The clinical and histopathological data collection allows making the NSA diagnosis. Thus, it was necessary to inquire again into the patient's relatives regarding the existence of similar lesions proving the presence of white plaques in oral mucosa in a son aged 19 and a daughter aged 25. The nevus spongiosus albus is an uncommon genetic lesion that must to be differentiated from other significant localized and systemic pathologies with serious repercussions for the subjects. Since there is not a curative treatment for the NSA, the role of the surgeon-dentist is to diagnose that lesion, to explain clearly to patient on the benign and self-limiting origin of this entity and if it is necessary from the aesthetic point of view, to apply the different therapeutical modalities to control the plaques(AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Tetraciclinas/uso terapêutico , Diagnóstico Diferencial , Leucoceratose da Mucosa Hereditária/terapia , Doenças da Boca/fisiopatologia
2.
J Oral Pathol Med ; 38(3): 289-98, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19267841

RESUMO

BACKGROUND: Toll-like receptors (TLR) are membrane proteins that recognize conserved molecules derived from bacterial, virus, fungal or host tissues. Activation of TLRs causes the production of cytokines that mediate inflammatory responses and drive T helper (Th) 1 and 2 cell development. As an exaggerated Th1 immune response is supposed to be involved in pathogenesis of Recurrent Aphthous Ulceration (RAU), we suggest that RAU patients may have an imbalance in TLR pathways. METHODS: To study the function of TLR activation ex vivo, peripheral blood mononuclear cells (PBMCs) from RAU patients (n = 17) and controls (n = 17) were exposed to TLR2 [lipoteichoic acid (LTA), heat-killed Listeria monocytogenes (HKLM) and PamC3CSK4], TLR3 [Poly(I:C)], TLR4 [lipopolysaccharide (LPS)], TLR5 (flagellin) and TLR7 (imiquimod) ligands, and the time course of supernatant tumor necrosis factor-alpha (TNF-alpha) levels was quantified by enzyme-linked immunosorbent assay. In addition, serological and salivary TNF-alpha and soluble CD14 levels were quantified. The TNF-alpha produced by PBMCs in contact with each TLR ligand and autologous serum or saliva at the same time was also investigated. The data were analyzed by statistical multivariate tests. RESULTS: The control group had a higher response to LTA, whereas RAU had a higher response to HKLM. LTA and LPS interfered with the salivary stimulation of the RAU PBMC and HKLM with the stimulation of the control. Autologous serum was capable of inhibiting TLR2 responsiveness to LTA and enhancing LPS stimulation. Salivary and serological levels of sCD14 and TNF-alpha were not significantly different. CONCLUSION: Recurrent Aphthous Ulceration patients have an anomalous activity of the TLR2 pathway that probably influences the stimulation of an abnormal Th1 immune response.


Assuntos
Estomatite Aftosa/imunologia , Células Th1/imunologia , Receptor 2 Toll-Like/agonistas , Receptor 2 Toll-Like/imunologia , Adolescente , Adulto , Idoso , Estudos de Casos e Controles , Análise por Conglomerados , Feminino , Humanos , Leucócitos Mononucleares/metabolismo , Modelos Lineares , Receptores de Lipopolissacarídeos/análise , Receptores de Lipopolissacarídeos/sangue , Masculino , Pessoa de Meia-Idade , Saliva/imunologia , Estomatite Aftosa/sangue , Receptor 2 Toll-Like/metabolismo , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/sangue , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA